Insys Therapeutics Agrees to Enter into $225 Million Global Resolution of Criminal and Civil Investigations
Date of publication: 07-10-2019
Opioids, Insys Therapeutics, mail fraud, kickbacks, Subsys, fentanyl, False Claims Act, bribes, illegal marketing, qui tam, Źródło: http://www.fda.gov
